{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:49:02Z","timestamp":1789674542245,"version":"4.0.1"},"reference-count":209,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,4,17]],"date-time":"2010-04-17T00:00:00Z","timestamp":1271462400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s11481-010-9203-1","type":"journal-article","created":{"date-parts":[[2010,4,15]],"date-time":"2010-04-15T22:03:12Z","timestamp":1271368992000},"page":"404-417","source":"Crossref","is-referenced-by-count":58,"title":["Molecular Regulation of JC Virus Tropism: Insights into Potential Therapeutic Targets for Progressive Multifocal Leukoencephalopathy"],"prefix":"10.1007","volume":"5","author":[{"given":"Leslie J.","family":"Marshall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene O.","family":"Major","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,17]]},"reference":[{"key":"9203_CR1","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/13550280152537292","volume":"7","author":"AJ Aksamit","year":"2001","unstructured":"Aksamit AJ (2001) Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside. J Neurovirology 7:386\u2013390","journal-title":"J Neurovirology"},{"key":"9203_CR2","first-page":"1498","volume":"30","author":"P Alla","year":"2001","unstructured":"Alla P, de Jaureguiberry JP, Gisserot O, Valance J, Jaubert D (2001) Progressive multifocal leucoencephalopathy in a patient with chronic lymphoid leukemia. Presse Med 30:1498\u20131499","journal-title":"Presse Med"},{"key":"9203_CR3","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1128\/JVI.00028-07","volume":"81","author":"T Allander","year":"2007","unstructured":"Allander T, Andreasson K, Gupta S, Bjerkner A, Bogdanovic G, Persson MA, Dalianis T, Ramqvist T, Andersson B (2007) Identification of a third human polyomavirus. J Virol 81:4130\u20134136","journal-title":"J Virol"},{"key":"9203_CR4","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.mehy.2005.01.037","volume":"65","author":"EL Altschuler","year":"2005","unstructured":"Altschuler EL, Kast RE (2005) The atypical antipsychotic agents ziprasidone [correction of zisprasidone], risperdone and olanzapine as treatment for and prophylaxis against progressive multifocal leukoencephalopathy. Med Hypotheses 65:585\u2013586","journal-title":"Med Hypotheses"},{"key":"9203_CR5","doi-asserted-by":"crossref","first-page":"7025","DOI":"10.1016\/S0021-9258(18)83535-9","volume":"264","author":"K Amemiya","year":"1989","unstructured":"Amemiya K, Traub R, Durham L, Major EO (1989) Interaction of a nuclear factor-1-like protein with the regulatory region of the human polyomavirus JC virus. J Biol Chem 264:7025\u20137032","journal-title":"J Biol Chem"},{"key":"9203_CR6","doi-asserted-by":"crossref","first-page":"14204","DOI":"10.1016\/S0021-9258(19)49698-1","volume":"267","author":"K Amemiya","year":"1992","unstructured":"Amemiya K, Traub R, Durham L, Major EO (1992) Adjacent nuclear factor-1 and activator protein binding sites in the enhancer of the neurotropic JC virus. A common characteristic of many brain-specific genes. J Biol Chem 267:14204\u201314211","journal-title":"J Biol Chem"},{"key":"9203_CR7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/prep.1994.1008","volume":"5","author":"K Amemiya","year":"1994","unstructured":"Amemiya K, Durham L, Major EO (1994) Overexpression and reactivation of binding activity of the recombinant CTF\/NF-1 transcription factor. Protein Expr Purif 5:57\u201364","journal-title":"Protein Expr Purif"},{"key":"9203_CR8","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1097\/00002030-199407000-00030","volume":"8","author":"A Antinori","year":"1994","unstructured":"Antinori A, De Luca A, Ammassari A, Cingolani A, Murri R, Colosimo G, Roselli R, Scerrati M, Tamburrini E (1994) Failure of cytarabine and increased JC virus-DNA burden in the cerebrospinal fluid of patients with AIDS-related progressive multifocal leucoencephalopathy. AIDS 8:1022\u20131024","journal-title":"AIDS"},{"key":"9203_CR9","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0248-8663(00)80026-0","volume":"21","author":"H Attout","year":"2000","unstructured":"Attout H, Rahmeh F, Lehuede G, Girardel M, Ziegler F (2000) Progressive multifocal leukoencephalopathy an chronic lymphocytic leukemia. Rev Med Interne 21:698\u2013700","journal-title":"Rev Med Interne"},{"key":"9203_CR10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/13550280152537157","volume":"7","author":"WJ Atwood","year":"2001","unstructured":"Atwood WJ (2001) A combination of low-dose chlorpromazine and neutralizing antibodies inhibits the spread of JC virus (JCV) in a tissue culture model: implications for prophylactic and therapeutic treatment of progressive multifocal leukoencephalopathy. J Neurovirology 7:307\u2013310","journal-title":"J Neurovirology"},{"key":"9203_CR11","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/0042-6822(92)90909-9","volume":"190","author":"WJ Atwood","year":"1992","unstructured":"Atwood WJ, Amemiya K, Traub R, Harms J, Major EO (1992) Interaction of the human polyomavirus, JCV, with human B-lymphocytes. Virology 190:716\u2013723","journal-title":"Virology"},{"key":"9203_CR12","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1099\/0022-1317-74-8-1499","volume":"74","author":"GS Ault","year":"1993","unstructured":"Ault GS, Stoner GL (1993) Human polyomavirus JC promoter\/enhancer rearrangement patterns from progressive multifocal leukoencephalopathy brain are unique derivatives of a single archetypal structure. J Gen Virol 74:1499\u20131507","journal-title":"J Gen Virol"},{"key":"9203_CR13","first-page":"1","volume":"23","author":"JA Aur","year":"1978","unstructured":"Aur JA, Simone JV, Verzosa MS, Hustu HO, Pinkel DP, Barker LF (1978) Leukoencephalopathy in children with acute lymphocytic leukemia receiving preventive central nervous system therapy (author\u2019s transl). Sangre (Barc) 23:1\u201312","journal-title":"Sangre (Barc)"},{"key":"9203_CR14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1468-1331.2001.00230.x","volume":"8","author":"F Bagnato","year":"2001","unstructured":"Bagnato F, Pietropoaolo V, Di Taranto C, Lorenzano S, Toni D (2001) Chronic lymphocytic leukemia complicated by progressive multifocal leukoencephalopathy without apparent immunodepression. Eur J Neurol 8:367\u2013368","journal-title":"Eur J Neurol"},{"key":"9203_CR15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ana.21363","volume":"63","author":"A Bar-Or","year":"2008","unstructured":"Bar-Or A, Calabresi PA, Arnold D, Markowitz C, Shafer S, Kasper LH, Waubant E, Gazda S, Fox RJ, Panzara M et al (2008) Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial. Ann Neurol 63:395\u2013400","journal-title":"Ann Neurol"},{"issue":"Suppl 1","key":"9203_CR16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/13550280390195342","volume":"9","author":"S Baum","year":"2003","unstructured":"Baum S, Ashok A, Gee G, Dimitrova S, Querbes W, Jordan J, Atwood WJ (2003) Early events in the life cycle of JC virus as potential therapeutic targets for the treatment of progressive multifocal leukoencephalopathy. J Neurovirology 9(Suppl 1):32\u201337","journal-title":"J Neurovirology"},{"key":"9203_CR17","first-page":"650","volume":"1","author":"A Behar","year":"1965","unstructured":"Behar A (1965) Progressive multifocal leukoencephalopathy in a case of acute lymphatic leukemia. Isr J Med Sci 1:650\u2013654","journal-title":"Isr J Med Sci"},{"key":"9203_CR18","unstructured":"Biogen (2009) Tysabri update, February 2009"},{"key":"9203_CR19","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1182\/blood-2007-09-112052","volume":"111","author":"H Bonig","year":"2008","unstructured":"Bonig H, Wundes A, Chang KH, Lucas S, Papayannopoulou T (2008) Increased numbers of circulating hematopoietic stem\/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab. Blood 111:3439\u20133441","journal-title":"Blood"},{"key":"9203_CR20","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1128\/AAC.01614-08","volume":"53","author":"M Brickelmaier","year":"2009","unstructured":"Brickelmaier M, Lugovskoy A, Kartikeyan R, Reviriego-Mendoza MM, Allaire N, Simon K, Frisque RJ, Gorelik L (2009) Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob Agents Chemother 53:1840\u20131849","journal-title":"Antimicrob Agents Chemother"},{"key":"9203_CR21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2141.1976.tb00184.x","volume":"34","author":"R Buckman","year":"1976","unstructured":"Buckman R, Wiltshaw E (1976) Letter: progressive multifocal leucoencephalopathy successfully treated with cytosine arabinoside. Br J Haematol 34:153\u2013158","journal-title":"Br J Haematol"},{"key":"9203_CR22","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","volume":"113","author":"KR Carson","year":"2009","unstructured":"Carson KR, Evens AM, Richey EA, Habermann TM, Focosi D, Seymour JF, Laubach J, Bawn SD, Gordon LI, Winter JN et al (2009) Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 113:4834\u20134840","journal-title":"Blood"},{"key":"9203_CR23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1517\/14712598.3.2.361","volume":"3","author":"JC Cather","year":"2003","unstructured":"Cather JC, Menter A (2003) Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab. Expert Opin Biol Ther 3:361\u2013370","journal-title":"Expert Opin Biol Ther"},{"key":"9203_CR24","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1128\/JVI.70.6.4150-4156.1996","volume":"70","author":"CF Chang","year":"1996","unstructured":"Chang CF, Gallia GL, Muralidharan V, Chen NN, Zoltick P, Johnson E, Khalili K (1996) Evidence that replication of human neurotropic JC virus DNA in glial cells is regulated by the sequence-specific single-stranded DNA-binding protein Pur alpha. J Virol 70:4150\u20134156","journal-title":"J Virol"},{"key":"9203_CR25","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1080\/13550280802235916","volume":"14","author":"ML Chapagain","year":"2008","unstructured":"Chapagain ML, Sumibcay L, Gurjav U, Kaufusi PH, Kast RE, Nerurkar VR (2008) Serotonin receptor 2A blocker (risperidone) has no effect on human polyomavirus JC infection of primary human fetal glial cells. J Neurovirology 14:448\u2013454","journal-title":"J Neurovirology"},{"key":"9203_CR26","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1128\/JVI.69.9.5843-5848.1995","volume":"69","author":"NN Chen","year":"1995","unstructured":"Chen NN, Khalili K (1995) Transcriptional regulation of human JC polyomavirus promoters by cellular proteins YB-1 and Pur alpha in glial cells. J Virol 69:5843\u20135848","journal-title":"J Virol"},{"key":"9203_CR27","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1073\/pnas.92.4.1087","volume":"92","author":"NN Chen","year":"1995","unstructured":"Chen NN, Chang CF, Gallia GL, Kerr DA, Johnson EM, Krachmarov CP, Barr SM, Frisque RJ, Bollag B, Khalili K (1995) Cooperative action of cellular proteins YB-1 and Pur alpha with the tumor antigen of the human JC polyomavirus determines their interaction with the viral lytic control element. Proc Natl Acad Sci USA 92:1087\u20131091","journal-title":"Proc Natl Acad Sci USA"},{"key":"9203_CR28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0378-1119(96)00630-0","volume":"185","author":"NN Chen","year":"1997","unstructured":"Chen NN, Kerr D, Chang CF, Honjo T, Khalili K (1997) Evidence for regulation of transcription and replication of the human neurotropic virus JCV genome by the human S(mu)bp-2 protein in glial cells. Gene 185:55\u201362","journal-title":"Gene"},{"key":"9203_CR29","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1056\/NEJMoa0904267","volume":"361","author":"Y Chen","year":"2009","unstructured":"Chen Y, Bord E, Tompkins T, Miller J, Tan CS, Kinkel RP, Stein MC, Viscidi RP, Ngo LH, Koralnik IJ (2009) Asymptomatic reactivation of JC virus in patients treated with natalizumab. N Engl J Med 361:1067\u20131074","journal-title":"N Engl J Med"},{"key":"9203_CR30","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/infdis\/147.4.676","volume":"147","author":"PM Chesters","year":"1983","unstructured":"Chesters PM, Heritage J, McCance DJ (1983) Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis 147:676\u2013684","journal-title":"J Infect Dis"},{"key":"9203_CR31","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s002779900149","volume":"79","author":"J Cid","year":"2000","unstructured":"Cid J, Revilla M, Cervera A, Cervantes F, Munoz E, Ferrer I, Montserrat E (2000) Progressive multifocal leukoencephalopathy following oral fludarabine treatment of chronic lymphocytic leukemia. Ann Hematol 79:392\u2013395","journal-title":"Ann Hematol"},{"key":"9203_CR32","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1001\/jama.1974.03230480029024","volume":"229","author":"JP Conomy","year":"1974","unstructured":"Conomy JP, Beard NS, Matsumoto H, Roessmann U (1974) Cytarabine treatment of progressive multifocal leukoencephalopathy. Clinical course and detection of virus-like particles after antiviral chemotherapy. JAMA 229:1313\u20131316","journal-title":"JAMA"},{"key":"9203_CR33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/sj.bmt.1701555","volume":"23","author":"P Coppo","year":"1999","unstructured":"Coppo P, Laporte JP, Aoudjhane M, Lebon P, Isnard F, Lesage S, Gorin NC, Najman A (1999) Progressive multifocal leucoencephalopathy with peripheral demyelinating neuropathy after autologous bone marrow transplantation for acute myeloblastic leukemia (FAB5). Bone Marrow Transplant 23:401\u2013403","journal-title":"Bone Marrow Transplant"},{"key":"9203_CR34","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/01.WNL.0000159399.81861.D5","volume":"64","author":"BA Cree","year":"2005","unstructured":"Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C (2005) An open label study of the effects of rituximab in neuromyelitis optica. Neurology 64:1270\u20131272","journal-title":"Neurology"},{"key":"9203_CR35","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.semcancer.2009.04.001","volume":"19","author":"T Dalianis","year":"2009","unstructured":"Dalianis T, Ramqvist T, Andreasson K, Kean JM, Garcea RL (2009) KI, WU and Merkel cell polyomaviruses: a new era for human polyomavirus research. Semin Cancer Biol 19:270\u2013275","journal-title":"Semin Cancer Biol"},{"key":"9203_CR36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/viro.1993.1239","volume":"194","author":"AM Daniel","year":"1993","unstructured":"Daniel AM, Frisque RJ (1993) Transcription initiation sites of prototype and variant JC virus early and late messenger RNAs. Virology 194:97\u2013109","journal-title":"Virology"},{"key":"9203_CR37","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1006\/viro.1996.0037","volume":"216","author":"AM Daniel","year":"1996","unstructured":"Daniel AM, Swenson JJ, Mayreddy RP, Khalili K, Frisque RJ (1996) Sequences within the early and late promoters of archetype JC virus restrict viral DNA replication and infectivity. Virology 216:90\u2013101","journal-title":"Virology"},{"key":"9203_CR38","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/med.20153","volume":"29","author":"E Clercq De","year":"2009","unstructured":"De Clercq E (2009) Another ten stories in antiviral drug discovery (part C): \u201cold\u201d and \u201cnew\u201d antivirals, strategies, and perspectives. Med Res Rev 29:611\u2013645","journal-title":"Med Res Rev"},{"key":"9203_CR39","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/10428190701281497","volume":"48","author":"RP Latour de","year":"2007","unstructured":"de Latour RP, Chaoui D, Bourhis JH, Belhocine R, Park S, Legrand O, Brault P, Rio B, Heshmati F, Assouad S et al (2007) Mobilization of peripheral blood progenitor cells after DHAP regimen with or without rituximab: a large multicenter comparative study in patients with malignant lymphoma. Leuk Lymphoma 48:897\u2013904","journal-title":"Leuk Lymphoma"},{"key":"9203_CR40","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1086\/515153","volume":"28","author":"A Luca De","year":"1999","unstructured":"De Luca A, Giancola ML, Cingolani A, Ammassari A, Gillini L, Murri R, Antinori A (1999) Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy. Clin Infect Dis 28:624\u2013628","journal-title":"Clin Infect Dis"},{"key":"9203_CR41","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/jmv.1890110406","volume":"11","author":"K Dorries","year":"1983","unstructured":"Dorries K, ter Meulen V (1983) Progressive multifocal leucoencephalopathy: detection of papovavirus JC in kidney tissue. J Med Virol 11:307\u2013317","journal-title":"J Med Virol"},{"key":"9203_CR42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/viro.1994.1008","volume":"198","author":"K Dorries","year":"1994","unstructured":"Dorries K, Vogel E, Gunther S, Czub S (1994) Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. Virology 198:59\u201370","journal-title":"Virology"},{"key":"9203_CR43","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1086\/597126","volume":"199","author":"A Egli","year":"2009","unstructured":"Egli A, Infanti L, Dumoulin A, Buser A, Samaridis J, Stebler C, Gosert R, Hirsch HH (2009) Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 199:837\u2013846","journal-title":"J Infect Dis"},{"key":"9203_CR44","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1126\/science.1103492","volume":"306","author":"GF Elphick","year":"2004","unstructured":"Elphick GF, Querbes W, Jordan JA, Gee GV, Eash S, Manley K, Dugan A, Stanifer M, Bhatnagar A, Kroeze WK et al (2004) The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306:1380\u20131383","journal-title":"Science"},{"key":"9203_CR45","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000109933","volume":"5","author":"B Engelhardt","year":"2008","unstructured":"Engelhardt B, Kappos L (2008) Natalizumab: targeting alpha4-integrins in multiple sclerosis. Neurodegener Dis 5:16\u201322","journal-title":"Neurodegener Dis"},{"key":"9203_CR46","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1128\/JVI.64.4.1657-1666.1990","volume":"64","author":"JR Erselius","year":"1990","unstructured":"Erselius JR, Jostes B, Hatzopoulos AK, Mosthaf L, Gruss P (1990) Cell-type-specific control elements of the lymphotropic papovavirus enhancer. J Virol 64:1657\u20131666","journal-title":"J Virol"},{"key":"9203_CR47","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2165\/00003495-200767030-00002","volume":"67","author":"MA Fanale","year":"2007","unstructured":"Fanale MA, Younes A (2007) Monoclonal antibodies in the treatment of non-Hodgkin\u2019s lymphoma. Drugs 67:333\u2013350","journal-title":"Drugs"},{"key":"9203_CR48","first-page":"318","volume":"8","author":"D Farge","year":"1994","unstructured":"Farge D, Herve R, Mikol J, Sauvaget F, Ingrand D, Singer B, Ferchal F, Auperin I, Gray F, Sudaka A et al (1994) Simultaneous progressive multifocal leukoencephalopathy, Epstein\u2013Barr virus (EBV) latent infection and cerebral parenchymal infiltration during chronic lymphocytic leukemia. Leukemia 8:318\u2013321","journal-title":"Leukemia"},{"key":"9203_CR49","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1126\/science.1152586","volume":"319","author":"H Feng","year":"2008","unstructured":"Feng H, Shuda M, Chang Y, Moore PS (2008) Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1096\u20131100","journal-title":"Science"},{"key":"9203_CR50","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/273113a0","volume":"273","author":"W Fiers","year":"1978","unstructured":"Fiers W, Contreras R, Haegemann G, Rogiers R, Van de Voorde A, Van Heuverswyn H, Van Herreweghe J, Volckaert G, Ysebaert M (1978) Complete nucleotide sequence of SV40 DNA. Nature 273:113\u2013120","journal-title":"Nature"},{"key":"9203_CR51","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0042-6822(91)90069-N","volume":"180","author":"T Flaegstad","year":"1991","unstructured":"Flaegstad T, Sundsfjord A, Arthur RR, Pedersen M, Traavik T, Subramani S (1991) Amplification and sequencing of the control regions of BK and JC virus from human urine by polymerase chain reaction. Virology 180:553\u2013560","journal-title":"Virology"},{"key":"9203_CR52","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2257.1989.tb00183.x","volume":"11","author":"P Flanagan","year":"1989","unstructured":"Flanagan P, Costello C (1989) Progressive multifocal leucoencephalopathy in patients with chronic lymphocytic leukaemia. Clin Lab Haematol 11:78\u201379","journal-title":"Clin Lab Haematol"},{"key":"9203_CR53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2165\/0128071-200910010-00009","volume":"10","author":"JE Frampton","year":"2009","unstructured":"Frampton JE, Plosker GL (2009) Efalizumab: a review of its use in the management of chronic moderate-to-severe plaque psoriasis. Am J Clin Dermatol 10:51\u201372","journal-title":"Am J Clin Dermatol"},{"key":"9203_CR54","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5414\/NPP26068","volume":"26","author":"SG Freim Wahl","year":"2007","unstructured":"Freim Wahl SG, Folvik MR, Torp SH (2007) Progressive multifocal leukoencephalopathy in a lymphoma patient with complete remission after treatment with cytostatics and rituximab: case report and review of the literature. Clin Neuropathol 26:68\u201373","journal-title":"Clin Neuropathol"},{"key":"9203_CR55","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1128\/JVI.46.1.170-176.1983","volume":"46","author":"RJ Frisque","year":"1983","unstructured":"Frisque RJ (1983a) Nucleotide sequence of the region encompassing the JC virus origin of DNA replication. J Virol 46:170\u2013176","journal-title":"J Virol"},{"key":"9203_CR56","first-page":"41","volume":"105","author":"RJ Frisque","year":"1983","unstructured":"Frisque RJ (1983b) Regulatory sequences and virus\u2013cell interactions of JC virus. Prog Clin Biol Res 105:41\u201359","journal-title":"Prog Clin Biol Res"},{"key":"9203_CR57","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1128\/JVI.51.2.458-469.1984","volume":"51","author":"RJ Frisque","year":"1984","unstructured":"Frisque RJ, Bream GL, Cannella MT (1984) Human polyomavirus JC virus genome. J Virol 51:458\u2013469","journal-title":"J Virol"},{"key":"9203_CR58","first-page":"684","volume":"32","author":"S Ganguly","year":"1995","unstructured":"Ganguly S, Ganguly SB, Biswas K (1995) Progressive multifocal leukoencephalopathy in a case of acute lymphocytic leukemia. Indian Pediatr 32:684\u2013686","journal-title":"Indian Pediatr"},{"key":"9203_CR59","first-page":"597","volume":"17","author":"K Garrels","year":"1996","unstructured":"Garrels K, Kucharczyk W, Wortzman G, Shandling M (1996) Progressive multifocal leukoencephalopathy: clinical and MR response to treatment. AJNR Am J Neuroradiol 17:597\u2013600","journal-title":"AJNR Am J Neuroradiol"},{"key":"9203_CR60","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2141.2008.07054.x","volume":"141","author":"B Garvey","year":"2008","unstructured":"Garvey B (2008) Rituximab in the treatment of autoimmune haematological disorders. Br J Haematol 141:149\u2013169","journal-title":"Br J Haematol"},{"key":"9203_CR61","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/088307388900400312","volume":"4","author":"CT Gay","year":"1989","unstructured":"Gay CT, Bodensteiner JB, Nitschke R, Sexauer C, Wilson D (1989) Reversible treatment-related leukoencephalopathy. J Child Neurol 4:208\u2013213","journal-title":"J Child Neurol"},{"key":"9203_CR62","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1371\/journal.ppat.0030064","volume":"3","author":"AM Gaynor","year":"2007","unstructured":"Gaynor AM, Nissen MD, Whiley DM, Mackay IM, Lambert SB, Wu G, Brennan DC, Storch GA, Sloots TP, Wang D (2007) Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog 3:e64","journal-title":"PLoS Pathog"},{"key":"9203_CR63","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0022-510X(78)90019-9","volume":"35","author":"MH GiaRusso","year":"1978","unstructured":"GiaRusso MH, Koeppen AH (1978) Atypical progressive multifocal leukoencephalopathy and primary cerebral malignant lymphoma. J Neurol Sci 35:391\u2013398","journal-title":"J Neurol Sci"},{"key":"9203_CR64","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1182\/blood.V99.4.1486","volume":"99","author":"SL Goldberg","year":"2002","unstructured":"Goldberg SL, Pecora AL, Alter RS, Kroll MS, Rowley SD, Waintraub SE, Imrit K, Preti RA (2002) Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab. Blood 99:1486\u20131488","journal-title":"Blood"},{"key":"9203_CR65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1389201003379059","volume":"1","author":"AJ Grillo-Lopez","year":"2000","unstructured":"Grillo-Lopez AJ, White CA, Dallaire BK, Varns CL, Shen CD, Wei A, Leonard JE, McClure A, Weaver R, Cairelli S et al (2000) Rituximab: the first monoclonal antibody approved for the treatment of lymphoma. Curr Pharm Biotechnol 1:1\u20139","journal-title":"Curr Pharm Biotechnol"},{"key":"9203_CR66","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/infdis\/147.4.669","volume":"147","author":"BW Grinnell","year":"1983","unstructured":"Grinnell BW, Padgett BL, Walker DL (1983) Distribution of nonintegrated DNA from JC papovavirus in organs of patients with progressive multifocal leukoencephalopathy. J Infect Dis 147:669\u2013675","journal-title":"J Infect Dis"},{"key":"9203_CR67","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0378-1119(00)00140-2","volume":"249","author":"RM Gronostajski","year":"2000","unstructured":"Gronostajski RM (2000) Roles of the NFI\/CTF gene family in transcription and development. Gene 249:31\u201345","journal-title":"Gene"},{"key":"9203_CR68","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1128\/MCB.5.5.964","volume":"5","author":"RM Gronostajski","year":"1985","unstructured":"Gronostajski RM, Adhya S, Nagata K, Guggenheimer RA, Hurwitz J (1985) Site-specific DNA binding of nuclear factor I: analyses of cellular binding sites. Mol Cell Biol 5:964\u2013971","journal-title":"Mol Cell Biol"},{"key":"9203_CR69","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJM199805073381903","volume":"338","author":"CD Hall","year":"1998","unstructured":"Hall CD, Dafni U, Simpson D, Clifford D, Wetherill PE, Cohen B, McArthur J, Hollander H, Yainnoutsos C, Major E et al (1998) Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. N Engl J Med 338:1345\u20131351","journal-title":"N Engl J Med"},{"key":"9203_CR70","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/hon.915","volume":"28","author":"M Hamadani","year":"2009","unstructured":"Hamadani M, Awan FT (2009) Remission induction, consolidation and novel agents in development for adults with acute myeloid leukaemia. Hematol Oncol 28:3\u201312","journal-title":"Hematol Oncol"},{"key":"9203_CR71","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s001150050601","volume":"70","author":"S Happe","year":"1999","unstructured":"Happe S, Besselmann M, Matheja P, Rickert CH, Schuierer G, Reichelt D, Husstedt IW (1999) Cidofovir (vistide) in therapy of progressive multifocal leukoencephalopathy in AIDS. Review of the literature and report of 2 cases. Nervenarzt 70:935\u2013943","journal-title":"Nervenarzt"},{"key":"9203_CR72","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1474-4422(08)70281-3","volume":"8","author":"HP Hartung","year":"2009","unstructured":"Hartung HP (2009) New cases of progressive multifocal leukoencephalopathy after treatment with natalizumab. Lancet Neurol 8:28\u201331","journal-title":"Lancet Neurol"},{"key":"9203_CR73","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1365-2141.2005.05587.x","volume":"130","author":"MM Hasan","year":"2005","unstructured":"Hasan MM, Taylor P (2005) Progressive multifocal leucoencephalopathy in a case of chronic lymphocytic leukaemia. Br J Haematol 130:808","journal-title":"Br J Haematol"},{"key":"9203_CR74","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","volume":"358","author":"SL Hauser","year":"2008","unstructured":"Hauser SL, Waubant E, Arnold DL, Vollmer T, Antel J, Fox RJ, Bar-Or A, Panzara M, Sarkar N, Agarwal S et al (2008) B-cell depletion with rituximab in relapsing\u2013remitting multiple sclerosis. N Engl J Med 358:676\u2013688","journal-title":"N Engl J Med"},{"key":"9203_CR75","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/ana.410370322","volume":"37","author":"W Heide","year":"1995","unstructured":"Heide W, Kompf D, Reusche E, Bodemer M, Weber T (1995) Failure of cytarabine\/interferon therapy in progressive multifocal leukoencephalopathy. Ann Neurol 37:412\u2013413","journal-title":"Ann Neurol"},{"key":"9203_CR76","first-page":"232","volume":"136","author":"J Heikens","year":"1992","unstructured":"Heikens J, van Berkel W, de Vos RA, van der Avoort HG, Krul MR (1992) Progressive multifocal leukoencephalopathy in a female patient with chronic lymphatic leukemia. Ned Tijdschr Geneeskd 136:232\u2013235","journal-title":"Ned Tijdschr Geneeskd"},{"key":"9203_CR77","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/314289a0","volume":"314","author":"L Hennighausen","year":"1985","unstructured":"Hennighausen L, Siebenlist U, Danner D, Leder P, Rawlins D, Rosenfeld P, Kelly T Jr (1985) High-affinity binding site for a specific nuclear protein in the human IgM gene. Nature 314:289\u2013292","journal-title":"Nature"},{"key":"9203_CR78","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0021-9258(17)42218-6","volume":"269","author":"JW Henson","year":"1994","unstructured":"Henson JW (1994) Regulation of the glial-specific JC virus early promoter by the transcription factor Sp1. J Biol Chem 269:1046\u20131050","journal-title":"J Biol Chem"},{"key":"9203_CR79","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ana.410320112","volume":"32","author":"J Henson","year":"1992","unstructured":"Henson J, Saffer J, Furneaux H (1992) The transcription factor Sp1 binds to the JC virus promoter and is selectively expressed in glial cells in human brain. Ann Neurol 32:72\u201377","journal-title":"Ann Neurol"},{"key":"9203_CR80","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1055\/s-2008-1068176","volume":"112","author":"H Hofeler","year":"1987","unstructured":"Hofeler H, Popescu O, Gunther B, Schmidt U, Hornung G, Hoffken K, Schmidt CG (1987) Progressive multifocal leukoencephalopathy. Late complication in chronic lymphatic leukemia. Dtsch Med Wochenschr 112:963\u2013966","journal-title":"Dtsch Med Wochenschr"},{"key":"9203_CR81","doi-asserted-by":"crossref","first-page":"373","DOI":"10.7326\/0003-4819-92-3-373","volume":"92","author":"TF Hogan","year":"1980","unstructured":"Hogan TF, Borden EC, McBain JA, Padgett BL, Walker DL (1980) Human polyomavirus infections with JC virus and BK virus in renal transplant patients. Ann Intern Med 92:373\u2013378","journal-title":"Ann Intern Med"},{"key":"9203_CR82","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1212\/WNL.28.8.794","volume":"28","author":"GV Horn","year":"1978","unstructured":"Horn GV, Bastian FO, Moake JL (1978) Progressive multifocal leukoencephalopathy: failure of response to transfer factor and cytarabine. Neurology 28:794\u2013797","journal-title":"Neurology"},{"key":"9203_CR83","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/13550289809114545","volume":"4","author":"J Hou","year":"1998","unstructured":"Hou J, Major EO (1998) The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line. J Neurovirology 4:451\u2013456","journal-title":"J Neurovirology"},{"key":"9203_CR84","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1056\/NEJM198802043180507","volume":"318","author":"SA Houff","year":"1988","unstructured":"Houff SA, Major EO, Katz DA, Kufta CV, Sever JL, Pittaluga S, Roberts JR, Gitt J, Saini N, Lux W (1988) Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. N Engl J Med 318:301\u2013305","journal-title":"N Engl J Med"},{"key":"9203_CR85","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF00165582","volume":"3","author":"TL Hwang","year":"1986","unstructured":"Hwang TL, Yung WK, Lee YY, Borit A, Fields WS (1986) High dose Ara-C related leukoencephalopathy. J Neuro-oncol 3:335\u2013339","journal-title":"J Neuro-oncol"},{"key":"9203_CR86","volume-title":"Biogen IDEC, Inc. Q2 2008 Earnings call transcript","author":"IDEC B","year":"2008","unstructured":"IDEC B (2008) Biogen IDEC, Inc. Q2 2008 Earnings call transcript. Biogen IDEC, Cambridge"},{"key":"9203_CR87","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1073\/pnas.90.11.5062","volume":"90","author":"T Iida","year":"1993","unstructured":"Iida T, Kitamura T, Guo J, Taguchi F, Aso Y, Nagashima K, Yogo Y (1993) Origin of JC polyomavirus variants associated with progressive multifocal leukoencephalopathy. Proc Natl Acad Sci USA 90:5062\u20135065","journal-title":"Proc Natl Acad Sci USA"},{"key":"9203_CR88","doi-asserted-by":"crossref","unstructured":"Jacquerioz FA, Croft AM (2009) Drugs for preventing malaria in travellers. Cochrane Database Syst Rev (Issue 4):Art. No. CD006491","DOI":"10.1002\/14651858.CD006491.pub2"},{"key":"9203_CR89","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/jlb.65.4.428","volume":"65","author":"PN Jensen","year":"1999","unstructured":"Jensen PN, Major EO (1999) Viral variant nucleotide sequences help expose leukocytic positioning in the JC virus pathway to the CNS. J Leukoc Biol 65:428\u2013438","journal-title":"J Leukoc Biol"},{"key":"9203_CR90","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0379-0738(94)90376-X","volume":"68","author":"R Jones","year":"1994","unstructured":"Jones R, Kunsman G, Levine B, Smith M, Stahl C (1994) Mefloquine distribution in postmortem cases. Forensic Sci Int 68:29\u201332","journal-title":"Forensic Sci Int"},{"key":"9203_CR91","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1128\/JVI.58.1.216-219.1986","volume":"58","author":"S Kenney","year":"1986","unstructured":"Kenney S, Natarajan V, Salzman NP (1986) Mapping 5\u2019 termini of JC virus late RNA. J Virol 58:216\u2013219","journal-title":"J Virol"},{"key":"9203_CR92","doi-asserted-by":"crossref","first-page":"7637","DOI":"10.1128\/JVI.68.11.7637-7643.1994","volume":"68","author":"D Kerr","year":"1994","unstructured":"Kerr D, Chang CF, Chen N, Gallia G, Raj G, Schwartz B, Khalili K (1994) Transcription of a human neurotropic virus promoter in glial cells: effect of YB-1 on expression of the JC virus late gene. J Virol 68:7637\u20137643","journal-title":"J Virol"},{"key":"9203_CR93","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1200\/JCO.2008.17.3047","volume":"26","author":"S Kesari","year":"2008","unstructured":"Kesari S, Akar S, Saad A, Drappatz J, Koralnik IJ, DeAngelo DJ (2008) Progressive multifocal leukoencephalopathy in a patient with relapsed acute myelogenous leukemia. J Clin Oncol 26:3804\u20133807","journal-title":"J Clin Oncol"},{"key":"9203_CR94","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1128\/JVI.60.3.935-942.1986","volume":"60","author":"K Khalili","year":"1986","unstructured":"Khalili K, Khoury G, Brady J (1986) Spacing between simian virus 40 early transcriptional control sequences is important for regulation of early RNA synthesis and gene expression. J Virol 60:935\u2013942","journal-title":"J Virol"},{"key":"9203_CR95","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1080\/1042819031000116625","volume":"44","author":"P Kiewe","year":"2003","unstructured":"Kiewe P, Seyfert S, Korper S, Rieger K, Thiel E, Knauf W (2003) Progressive multifocal leukoencephalopathy with detection of JC virus in a patient with chronic lymphocytic leukemia parallel to onset of fludarabine therapy. Leuk Lymphoma 44:1815\u20131818","journal-title":"Leuk Lymphoma"},{"key":"9203_CR96","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1128\/JVI.77.9.5241-5252.2003","volume":"77","author":"J Kim","year":"2003","unstructured":"Kim J, Woolridge S, Biffi R, Borghi E, Lassak A, Ferrante P, Amini S, Khalili K, Safak M (2003) Members of the AP-1 family, c-Jun and c-Fos, functionally interact with JC virus early regulatory protein large T antigen. J Virol 77:5241\u20135252","journal-title":"J Virol"},{"key":"9203_CR97","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.virol.2004.06.021","volume":"327","author":"SY Kim","year":"2004","unstructured":"Kim SY, Choi EC, Woo Jo Y, Henson JW, Kim HS (2004) Transcriptional activation of JC virus early promoter by phorbol ester and interleukin-1beta: critical role of nuclear factor-1. Virology 327:60\u201369","journal-title":"Virology"},{"key":"9203_CR98","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bbrc.2006.03.165","volume":"344","author":"SY Kim","year":"2006","unstructured":"Kim SY, Kim DH, Hyun JW, Henson JW, Kim HS (2006) Irisolidone, an isoflavone metabolite, represses JC virus gene expression via inhibition of Sp1 binding in human glial cells. Biochem Biophys Res Commun 344:3\u20138","journal-title":"Biochem Biophys Res Commun"},{"key":"9203_CR99","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJMoa051782","volume":"353","author":"BK Kleinschmidt-DeMasters","year":"2005","unstructured":"Kleinschmidt-DeMasters BK, Tyler KL (2005) Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 353:369\u2013374","journal-title":"N Engl J Med"},{"key":"9203_CR100","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1128\/JVI.69.4.2434-2442.1995","volume":"69","author":"CJ Krebs","year":"1995","unstructured":"Krebs CJ, McAvoy MT, Kumar G (1995) The JC virus minimal core promoter is glial cell specific in vivo. J Virol 69:2434\u20132442","journal-title":"J Virol"},{"key":"9203_CR101","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1212\/01.wnl.0000327671.91357.96","volume":"71","author":"M Krumbholz","year":"2008","unstructured":"Krumbholz M, Meinl I, Kumpfel T, Hohlfeld R, Meinl E (2008) Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis. Neurology 71:1350\u20131354","journal-title":"Neurology"},{"key":"9203_CR102","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1128\/JVI.67.1.572-576.1993","volume":"67","author":"KU Kumar","year":"1993","unstructured":"Kumar KU, Pater A, Pater MM (1993) Human JC virus perfect palindromic nuclear factor 1-binding sequences important for glial cell-specific expression in differentiating embryonal carcinoma cells. J Virol 67:572\u2013576","journal-title":"J Virol"},{"key":"9203_CR103","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1046\/j.1471-4159.1996.67020473.x","volume":"67","author":"KU Kumar","year":"1996","unstructured":"Kumar KU, Devireddy LR, Tang SC, Pater A, Pater MM (1996) Human JC virus nuclear factor 1 binding motifs and large tumor antigen region required for transactivation of late promoter. J Neurochem 67:473\u2013481","journal-title":"J Neurochem"},{"key":"9203_CR104","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJMoa051847","volume":"353","author":"A Langer-Gould","year":"2005","unstructured":"Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D (2005) Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 353:375\u2013381","journal-title":"N Engl J Med"},{"key":"9203_CR105","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/0042-6822(79)90113-2","volume":"96","author":"MF Law","year":"1979","unstructured":"Law MF, Martin JD, Takemoto KK, Howley PM (1979) The colinear alignment of the genomes of papovaviruses JC, BK, and SV40. Virology 96:576\u2013587","journal-title":"Virology"},{"key":"9203_CR106","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/art.21617","volume":"54","author":"MJ Leandro","year":"2006","unstructured":"Leandro MJ, Cambridge G, Ehrenstein MR, Edwards JC (2006) Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis. Arthritis Rheum 54:613\u2013620","journal-title":"Arthritis Rheum"},{"key":"9203_CR107","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/j.1460-2075.1985.tb03811.x","volume":"4","author":"PA Leegwater","year":"1985","unstructured":"Leegwater PA, Van Driel W, van der Vliet PC (1985) Recognition site of nuclear factor I, a sequence-specific DNA-binding protein from HeLa cells that stimulates adenovirus DNA replication. EMBO J 4:1515\u20131521","journal-title":"EMBO J"},{"key":"9203_CR108","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1128\/MCB.15.7.3738","volume":"15","author":"H Leger","year":"1995","unstructured":"Leger H, Sock E, Renner K, Grummt F, Wegner M (1995) Functional interaction between the POU domain protein Tst-1\/Oct-6 and the high-mobility-group protein HMG-I\/Y. Mol Cell Biol 15:3738\u20133747","journal-title":"Mol Cell Biol"},{"key":"9203_CR109","first-page":"1121","volume":"158","author":"S Leonard","year":"2002","unstructured":"Leonard S, Hulin C, Anxionnat R, Grignon Y, Taillandier L, Vespignani H (2002) Multifocal progressive leukoencephalitis in a patient given fludarabine for chronic lymphoid leukemia. Rev Neurol (Paris) 158:1121\u20131123","journal-title":"Rev Neurol (Paris)"},{"key":"9203_CR110","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/13550280152537283","volume":"7","author":"RM Levy","year":"2001","unstructured":"Levy RM, Major E, Ali MJ, Cohen B, Groothius D (2001) Convection-enhanced intraparenchymal delivery (CEID) of cytosine arabinoside (AraC) for the treatment of HIV-related progressive multifocal leukoencephalopathy (PML). J Neurovirology 7:382\u2013385","journal-title":"J Neurovirology"},{"key":"9203_CR111","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa0810316","volume":"361","author":"H Linda","year":"2009","unstructured":"Linda H, von Heijne A, Major EO, Ryschkewitsch C, Berg J, Olsson T, Martin C (2009) Progressive multifocal leukoencephalopathy after natalizumab monotherapy. N Engl J Med 361:1081\u20131087","journal-title":"N Engl J Med"},{"key":"9203_CR112","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jneuroim.2007.11.007","volume":"194","author":"RL Lindberg","year":"2008","unstructured":"Lindberg RL, Achtnichts L, Hoffmann F, Kuhle J, Kappos L (2008) Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients. J Neuroimmunol 194:153\u2013164","journal-title":"J Neuroimmunol"},{"key":"9203_CR113","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.tips.2008.07.012","volume":"29","author":"RA Linker","year":"2008","unstructured":"Linker RA, Kieseier BC, Gold R (2008) Identification and development of new therapeutics for multiple sclerosis. Trends Pharmacol Sci 29:558\u2013565","journal-title":"Trends Pharmacol Sci"},{"key":"9203_CR114","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1128\/JVI.72.6.4643-4649.1998","volume":"72","author":"CK Liu","year":"1998","unstructured":"Liu CK, Wei G, Atwood WJ (1998) Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal alpha(2-6)-linked sialic acids. J Virol 72:4643\u20134649","journal-title":"J Virol"},{"key":"9203_CR115","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1128\/JVI.62.5.1730-1735.1988","volume":"62","author":"G Loeber","year":"1988","unstructured":"Loeber G, Dorries K (1988) DNA rearrangements in organ-specific variants of polyomavirus JC strain GS. J Virol 62:1730\u20131735","journal-title":"J Virol"},{"key":"9203_CR116","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJMp0906248","volume":"361","author":"EO Major","year":"2009","unstructured":"Major EO (2009) Reemergence of PML in natalizumab-treated patients\u2014new cases, same concerns. N Engl J Med 361:1041\u20131043","journal-title":"N Engl J Med"},{"key":"9203_CR117","doi-asserted-by":"crossref","first-page":"8.1","DOI":"10.1146\/annurev.med.080708.082655","volume":"61","author":"EO Major","year":"2010","unstructured":"Major EO (2010) Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu Rev Med 61:8.1\u20138.13","journal-title":"Annu Rev Med"},{"key":"9203_CR118","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/jnr.490270405","volume":"27","author":"EO Major","year":"1990","unstructured":"Major EO, Amemiya K, Elder G, Houff SA (1990) Glial cells of the human developing brain and B cells of the immune system share a common DNA binding factor for recognition of the regulatory sequences of the human polyomavirus, JCV. J Neurosci Res 27:461\u2013471","journal-title":"J Neurosci Res"},{"key":"9203_CR119","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0035-3787(06)74985-2","volume":"162","author":"I Malkoun","year":"2006","unstructured":"Malkoun I, Vidry E, Revenco E, Drobacheff MC, Berger E, Rumbach L (2006) Role of immunity in the development of progressive multifocal leukoencephalopathy: a report of three patients with type B lymphoma and humoral immunodeficiency and six others with acquired immunodeficiency syndrome. Rev Neurol (Paris) 162:82\u201388","journal-title":"Rev Neurol (Paris)"},{"key":"9203_CR120","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1182\/blood.V90.6.2188","volume":"90","author":"DG Maloney","year":"1997","unstructured":"Maloney DG, Grillo-Lopez AJ, White CA, Bodkin D, Schilder RJ, Neidhart JA, Janakiraman N, Foon KA, Liles TM, Dallaire BK et al (1997) IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin\u2019s lymphoma. Blood 90:2188\u20132195","journal-title":"Blood"},{"key":"9203_CR121","doi-asserted-by":"crossref","first-page":"12079","DOI":"10.1128\/JVI.01456-06","volume":"80","author":"K Manley","year":"2006","unstructured":"Manley K, O\u2019Hara BA, Gee GV, Simkevich CP, Sedivy JM, Atwood WJ (2006) NFAT4 is required for JC virus infection of glial cells. J Virol 80:12079\u201312085","journal-title":"J Virol"},{"key":"9203_CR122","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/jnnp.38.3.205","volume":"38","author":"PJ Marriott","year":"1975","unstructured":"Marriott PJ, O\u2019Brien MD, Mackenzie IC, Janota I (1975) Progressive multifocal leucoencephalopathy: remission with cytarabine. J Neurol Neurosurg Psychiatry 38:205\u2013209","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9203_CR123","unstructured":"Marshall LJ, Ryschkewitsch C, Jensen PN, Major EO (2009) Acquisition of unique Spi-B binding sites in the JC virus promoter: a potential susceptibility factor for development of progressive multifocal leukoencephalopathy. Presented at Am Soc Virol Annu Meet, 28th, Vancouver, Canada"},{"key":"9203_CR124","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1128\/JVI.53.1.306-311.1985","volume":"53","author":"JD Martin","year":"1985","unstructured":"Martin JD, King DM, Slauch JM, Frisque RJ (1985) Differences in regulatory sequences of naturally occurring JC virus variants. J Virol 53:306\u2013311","journal-title":"J Virol"},{"key":"9203_CR125","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/13550280802356837","volume":"14","author":"A Marzocchetti","year":"2008","unstructured":"Marzocchetti A, Wuthrich C, Tan CS, Tompkins T, Bernal-Cano F, Bhargava P, Ropper AH, Koralnik IJ (2008) Rearrangement of the JC virus regulatory region sequence in the bone marrow of a patient with rheumatoid arthritis and progressive multifocal leukoencephalopathy. J Neurovirology 14:455\u2013458","journal-title":"J Neurovirology"},{"key":"9203_CR126","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0025-7753(00)71634-4","volume":"115","author":"MI Mata","year":"2000","unstructured":"Mata MI, Gardella S, del Mar CM, Ortiz MR (2000) Progressive multifocal leukoencephalopathy in a patient with chronic lymphatic leukemia treated with fludarabine. Med Clin (Barc) 115:598\u2013599","journal-title":"Med Clin (Barc)"},{"key":"9203_CR127","first-page":"27","volume":"47","author":"T Matsuo","year":"2007","unstructured":"Matsuo T, Kyoraku I, Shiomi K, Sugimoto S, Zheng HY, Nakazato M (2007) Detection of novel rearrangement of the JC virus gene in a case of progressive multifocal leukoencephalopathy with adult T-cell leukemia. Rinsho Shinkeigaku 47:27\u201331","journal-title":"Rinsho Shinkeigaku"},{"key":"9203_CR128","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1128\/JVI.70.4.2387-2393.1996","volume":"70","author":"RP Mayreddy","year":"1996","unstructured":"Mayreddy RP, Safak M, Razmara M, Zoltick P, Khalili K (1996) Transcription of the JC virus archetype late genome: importance of the kappa B and the 23-base-pair motifs in late promoter activity in glial cells. J Virol 70:2387\u20132393","journal-title":"J Virol"},{"key":"9203_CR129","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/ana.10523","volume":"53","author":"CA Messam","year":"2003","unstructured":"Messam CA, Hou J, Gronostajski RM, Major EO (2003) Lineage pathway of human brain progenitor cells identified by JC virus susceptibility. Ann Neurol 53:636\u2013646","journal-title":"Ann Neurol"},{"key":"9203_CR130","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/jcp.20375","volume":"204","author":"M Mischitelli","year":"2005","unstructured":"Mischitelli M, Fioriti D, Videtta M, Degener AM, Antinori A, Cinque P, Giordano A, Pietropaolo V (2005) Investigation on the role of cell transcriptional factor Sp1 and HIV-1 TAT protein in PML onset or development. J Cell Physiol 204:913\u2013918","journal-title":"J Cell Physiol"},{"key":"9203_CR131","volume-title":"Culture of human fetal brain progenitor derived oligodendrocytes","author":"MC Monaco","year":"2009","unstructured":"Monaco MC, Major EO (2009) Culture of human fetal brain progenitor derived oligodendrocytes. National Institute of Neurological Disease and Stroke, National Institutes of Health, Bethesda"},{"key":"9203_CR132","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1128\/JVI.70.10.7004-7012.1996","volume":"70","author":"MC Monaco","year":"1996","unstructured":"Monaco MC, Atwood WJ, Gravell M, Tornatore CS, Major EO (1996) JC virus infection of hematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: implications for viral latency. J Virol 70:7004\u20137012","journal-title":"J Virol"},{"key":"9203_CR133","doi-asserted-by":"crossref","first-page":"9918","DOI":"10.1128\/JVI.72.12.9918-9923.1998","volume":"72","author":"MC Monaco","year":"1998","unstructured":"Monaco MC, Jensen PN, Hou J, Durham LC, Major EO (1998) Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection. J Virol 72:9918\u20139923","journal-title":"J Virol"},{"key":"9203_CR134","doi-asserted-by":"crossref","first-page":"9687","DOI":"10.1128\/JVI.75.20.9687-9695.2001","volume":"75","author":"MC Monaco","year":"2001","unstructured":"Monaco MC, Sabath BF, Durham LC, Major EO (2001) JC virus multiplication in human hematopoietic progenitor cells requires the NF-1 class D transcription factor. J Virol 75:9687\u20139695","journal-title":"J Virol"},{"key":"9203_CR135","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archneur.62.2.258","volume":"62","author":"NL Monson","year":"2005","unstructured":"Monson NL, Cravens PD, Frohman EM, Hawker K, Racke MK (2005) Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis. Arch Neurol 62:258\u2013264","journal-title":"Arch Neurol"},{"key":"9203_CR136","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/clinids\/23.5.1066","volume":"23","author":"S Moreno","year":"1996","unstructured":"Moreno S, Miralles P, Diaz MD, Berenguer J, Bernaldo de Quiros JC, Blazquez R, Cosin J, Bouza E (1996) Cytarabine therapy for progressive multifocal leukoencephalopathy in patients with AIDS. Clin Infect Dis 23:1066\u20131068","journal-title":"Clin Infect Dis"},{"key":"9203_CR137","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1097\/TP.0b013e31818b62c8","volume":"86","author":"RT Neff","year":"2008","unstructured":"Neff RT, Hurst FP, Falta EM, Bohen EM, Lentine KL, Dharnidharka VR, Agodoa LY, Jindal RM, Yuan CM, Abbott KC (2008) Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation. Transplantation 86:1474\u20131478","journal-title":"Transplantation"},{"key":"9203_CR138","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/0140-6736(92)91376-J","volume":"339","author":"F Nicoli","year":"1992","unstructured":"Nicoli F, Chave B, Peragut JC, Gastaut JL (1992) Efficacy of cytarabine in progressive multifocal leucoencephalopathy in AIDS. Lancet 339:306","journal-title":"Lancet"},{"key":"9203_CR139","first-page":"905","volume":"27","author":"T Nowak-Michalska","year":"1993","unstructured":"Nowak-Michalska T, Barcikowska M, Kida E, Budka H, Liberski PP (1993) A case of progressive multifocal leucoencephalopathy during chronic lymphocytic leukaemia. Neurol Neurochir Pol 27:905\u2013912","journal-title":"Neurol Neurochir Pol"},{"key":"9203_CR140","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/nar\/13.6.2045","volume":"13","author":"J Nowock","year":"1985","unstructured":"Nowock J, Borgmeyer U, Puschel AW, Rupp RA, Sippel AE (1985) The TGGCA protein binds to the MMTV-LTR, the adenovirus origin of replication, and the BK virus enhancer. Nucleic Acids Res 13:2045\u20132061","journal-title":"Nucleic Acids Res"},{"key":"9203_CR141","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0163-4453(90)92324-E","volume":"20","author":"T O\u2019Riordan","year":"1990","unstructured":"O\u2019Riordan T, Daly PA, Hutchinson M, Shattock AG, Gardner SD (1990) Progressive multifocal leukoencephalopathy-remission with cytarabine. J Infect 20:51\u201354","journal-title":"J Infect"},{"key":"9203_CR142","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00277-007-0411-6","volume":"87","author":"M Pelosini","year":"2008","unstructured":"Pelosini M, Focosi D, Rita F, Galimberti S, Caracciolo F, Benedetti E, Papineschi F, Petrini M (2008) Progressive multifocal leukoencephalopathy: report of three cases in HIV-negative hematological patients and review of literature. Ann Hematol 87:405\u2013412","journal-title":"Ann Hematol"},{"key":"9203_CR143","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1101\/gad.1.9.962","volume":"1","author":"M Pettersson","year":"1987","unstructured":"Pettersson M, Schaffner W (1987) A purine-rich DNA sequence motif present in SV40 and lymphotropic papovavirus binds a 1ymphoid-specific factor and contributes to enhancer activity in 1ymphoid ce11s. Genes Dev 1:962\u2013972","journal-title":"Genes Dev"},{"key":"9203_CR144","first-page":"58","volume":"37","author":"YT Pham","year":"1999","unstructured":"Pham YT, Nosten F, Farinotti R, White NJ, Gimenez F (1999) Cerebral uptake of mefloquine enantiomers in fatal cerebral malaria. Int J Clin Pharmacol Ther 37:58\u201361","journal-title":"Int J Clin Pharmacol Ther"},{"key":"9203_CR145","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00401-009-0533-0","volume":"118","author":"S Pina-Oviedo","year":"2009","unstructured":"Pina-Oviedo S, Khalili K, Del Valle L (2009) Hypoxia inducible factor-1 alpha activation of the JCV promoter: role in the pathogenesis of progressive multifocal leukoencephalopathy. Acta Neuropathol 118:235\u2013247","journal-title":"Acta Neuropathol"},{"key":"9203_CR146","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000112916","volume":"50","author":"C Pohlmann","year":"2007","unstructured":"Pohlmann C, Hochauf K, Rollig C, Schetelig J, Wunderlich O, Bandt D, Ehninger G, Jacobs E, Rohayem J (2007) Chlorpromazine combined with cidofovir for treatment of a patient suffering from progressive multifocal leukoencephalopathy. Intervirology 50:412\u2013417","journal-title":"Intervirology"},{"key":"9203_CR147","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/0140-6736(91)92504-U","volume":"337","author":"P Portegies","year":"1991","unstructured":"Portegies P, Algra PR, Hollak CE, Prins JM, Reiss P, Valk J, Lange JM (1991) Response to cytarabine in progressive multifocal leucoencephalopathy in AIDS. Lancet 337:680\u2013681","journal-title":"Lancet"},{"key":"9203_CR148","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/sj.bmt.1701010","volume":"20","author":"D Przepiorka","year":"1997","unstructured":"Przepiorka D, Jaeckle KA, Birdwell RR, Fuller GN, Kumar AJ, Huh YO, McCutcheon I (1997) Successful treatment of progressive multifocal leukoencephalopathy with low-dose interleukin-2. Bone Marrow Transplant 20:983\u2013987","journal-title":"Bone Marrow Transplant"},{"key":"9203_CR149","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1177\/0961203309106174","volume":"18","author":"M Ramos-Casals","year":"2009","unstructured":"Ramos-Casals M, Soto MJ, Cuadrado MJ, Khamashta MA (2009) Rituximab in systemic lupus erythematosus: a systematic review of off-label use in 188 cases. Lupus 18:767\u2013776","journal-title":"Lupus"},{"key":"9203_CR150","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.410010509","volume":"1","author":"KH Rand","year":"1977","unstructured":"Rand KH, Johnson KP, Rubinstein LJ, Wolinsky JS, Penney JB, Walker DL, Padgett BL, Merigan TC (1977) Adenine arabinoside in the treatment of progressive multifocal leukoencephalopathy: use of virus-containing cells in the urine to assess response to therapy. Ann Neurol 1:458\u2013462","journal-title":"Ann Neurol"},{"key":"9203_CR151","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/nar\/21.8.1959","volume":"21","author":"PN Ranganathan","year":"1993","unstructured":"Ranganathan PN, Khalili K (1993) The transcriptional enhancer element, kappa B, regulates promoter activity of the human neurotropic virus, JCV, in cells derived from the CNS. Nucleic Acids Res 21:1959\u20131964","journal-title":"Nucleic Acids Res"},{"key":"9203_CR152","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1099\/vir.0.2008\/000059-0","volume":"89","author":"V Ravichandran","year":"2008","unstructured":"Ravichandran V, Major EO (2008) DNA-binding transcription factor NF-1A negatively regulates JC virus multiplication. J Gen Virol 89:1396\u20131401","journal-title":"J Gen Virol"},{"key":"9203_CR153","doi-asserted-by":"crossref","first-page":"10506","DOI":"10.1128\/JVI.01355-06","volume":"80","author":"V Ravichandran","year":"2006","unstructured":"Ravichandran V, Sabath BF, Jensen PN, Houff SA, Major EO (2006) Interactions between c-Jun, nuclear factor 1, and JC virus promoter sequences: implications for viral tropism. J Virol 80:10506\u201310513","journal-title":"J Virol"},{"key":"9203_CR154","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1126\/science.205947","volume":"200","author":"VB Reddy","year":"1978","unstructured":"Reddy VB, Thimmappaya B, Dhar R, Subramanian KN, Zain BS, Pan J, Ghosh PK, Celma ML, Weissman SM (1978) The genome of simian virus 40. Science 200:494\u2013502","journal-title":"Science"},{"key":"9203_CR155","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1093\/nar\/24.22.4552","volume":"24","author":"K Renner","year":"1996","unstructured":"Renner K, Sock E, Bermingham JR Jr, Wegner M (1996a) Expression of the gene for the POU domain transcription factor Tst-1\/Oct6 is regulated by an estrogen-dependent enhancer. Nucleic Acids Res 24:4552\u20134557","journal-title":"Nucleic Acids Res"},{"key":"9203_CR156","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1089\/dna.1996.15.1057","volume":"15","author":"K Renner","year":"1996","unstructured":"Renner K, Sock E, Gerber JK, Wegner M (1996b) T antigen of human papovavirus JC stimulates transcription of the POU domain factor Tst-1\/Oct6\/SCIP. DNA Cell Biol 15:1057\u20131062","journal-title":"DNA Cell Biol"},{"key":"9203_CR157","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1212\/01.WNL.0000158329.30470.D0","volume":"64","author":"GP Rice","year":"2005","unstructured":"Rice GP, Hartung HP, Calabresi PA (2005) Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale. Neurology 64:1336\u20131342","journal-title":"Neurology"},{"key":"9203_CR158","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1001\/archneur.63.7.1028","volume":"63","author":"J Robb","year":"2006","unstructured":"Robb J, Chalmers L, Rojiani A, Chamberlain M (2006) Multifocal necrotizing leukoencephalopathy: an unusual complication of acute leukemia. Arch Neurol 63:1028\u20131029","journal-title":"Arch Neurol"},{"key":"9203_CR159","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1002\/art.22019","volume":"54","author":"P Roll","year":"2006","unstructured":"Roll P, Palanichamy A, Kneitz C, Dorner T, Tony HP (2006) Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis. Arthritis Rheum 54:2377\u20132386","journal-title":"Arthritis Rheum"},{"key":"9203_CR160","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/art.23473","volume":"58","author":"P Roll","year":"2008","unstructured":"Roll P, Dorner T, Tony HP (2008) Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment. Arthritis Rheum 58:1566\u20131575","journal-title":"Arthritis Rheum"},{"key":"9203_CR161","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.virol.2008.02.021","volume":"375","author":"L Romagnoli","year":"2008","unstructured":"Romagnoli L, Sariyer IK, Tung J, Feliciano M, Sawaya BE, Del Valle L, Ferrante P, Khalili K, Safak M, White MK (2008) Early growth response-1 protein is induced by JC virus infection and binds and regulates the JC virus promoter. Virology 375:331\u2013341","journal-title":"Virology"},{"key":"9203_CR162","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.virusres.2009.09.005","volume":"146","author":"L Romagnoli","year":"2009","unstructured":"Romagnoli L, Wollebo HS, Deshmane SL, Mukerjee R, Del Valle L, Safak M, Khalili K, White MK (2009) Modulation of JC virus transcription by C\/EBPbeta. Virus Res 146:97\u2013106","journal-title":"Virus Res"},{"issue":"Suppl 6","key":"9203_CR163","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00415-008-6006-x","volume":"255","author":"PS Rommer","year":"2008","unstructured":"Rommer PS, Stuve O, Goertsches R, Mix E, Zettl UK (2008) Monoclonal antibodies in the therapy of multiple sclerosis: an overview. J Neurol 255(Suppl 6):28\u201335","journal-title":"J Neurol"},{"key":"9203_CR164","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/JVI.77.1.665-672.2003","volume":"77","author":"B Sadowska","year":"2003","unstructured":"Sadowska B, Barrucco R, Khalili K, Safak M (2003) Regulation of human polyomavirus JC virus gene transcription by AP-1 in glial cells. J Virol 77:665\u2013672","journal-title":"J Virol"},{"key":"9203_CR165","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1080\/13550280152537111","volume":"7","author":"M Safak","year":"2001","unstructured":"Safak M, Khalili K (2001) Physical and functional interaction between viral and cellular proteins modulate JCV gene transcription. J Neurovirology 7:288\u2013292","journal-title":"J Neurovirology"},{"key":"9203_CR166","doi-asserted-by":"crossref","first-page":"10146","DOI":"10.1128\/JVI.73.12.10146-10157.1999","volume":"73","author":"M Safak","year":"1999","unstructured":"Safak M, Gallia GL, Ansari SA, Khalili K (1999) Physical and functional interaction between the Y-box binding protein YB-1 and human polyomavirus JC virus large T antigen. J Virol 73:10146\u201310157","journal-title":"J Virol"},{"key":"9203_CR167","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1128\/JVI.76.8.3828-3838.2002","volume":"76","author":"M Safak","year":"2002","unstructured":"Safak M, Sadowska B, Barrucco R, Khalili K (2002) Functional interaction between JC virus late regulatory agnoprotein and cellular Y-box binding transcription factor, YB-1. J Virol 76:3828\u20133838","journal-title":"J Virol"},{"key":"9203_CR168","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/10428190290006297","volume":"43","author":"M Saumoy","year":"2002","unstructured":"Saumoy M, Castells G, Escoda L, Mares R, Richart C, Ugarriza A (2002) Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia after treatment with fludarabine. Leuk Lymphoma 43:433\u2013436","journal-title":"Leuk Lymphoma"},{"key":"9203_CR169","doi-asserted-by":"crossref","first-page":"8896","DOI":"10.1128\/JVI.00406-08","volume":"82","author":"C Schaumburg","year":"2008","unstructured":"Schaumburg C, O\u2019Hara BA, Lane TE, Atwood WJ (2008) Human embryonic stem cell-derived oligodendrocyte progenitor cells express the serotonin receptor and are susceptible to JC virus infection. J Virol 82:8896\u20138899","journal-title":"J Virol"},{"key":"9203_CR170","first-page":"1271","volume":"25","author":"EM Schneider","year":"1993","unstructured":"Schneider EM, Dorries K (1993) High frequency of polyomavirus infection in lymphoid cell preparations after allogeneic bone marrow transplantation. Transplant Proc 25:1271\u20131273","journal-title":"Transplant Proc"},{"key":"9203_CR171","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.clindermatol.2007.10.027","volume":"26","author":"MP Schon","year":"2008","unstructured":"Schon MP (2008) Efalizumab in the treatment of psoriasis: mode of action, clinical indications, efficacy, and safety. Clin Dermatol 26:509\u2013514","journal-title":"Clin Dermatol"},{"key":"9203_CR172","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1592\/phco.27.12.1702","volume":"27","author":"AA Schuna","year":"2007","unstructured":"Schuna AA (2007) Rituximab for the treatment of rheumatoid arthritis. Pharmacotherapy 27:1702\u20131710","journal-title":"Pharmacotherapy"},{"key":"9203_CR173","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/0092-8674(79)90209-5","volume":"18","author":"I Seif","year":"1979","unstructured":"Seif I, Khoury G, Dhar R (1979) The genome of human papovavirus BKV. Cell 18:963\u2013977","journal-title":"Cell"},{"key":"9203_CR174","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/clinids\/23.2.402","volume":"23","author":"D Seong","year":"1996","unstructured":"Seong D, Bruner JM, Lee KH, Mirza N, Kwon BD, Lee JH, Lee YY, Ro J, Talpaz M, Champlin R et al (1996) Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation in a patient with chronic myelogenous leukemia. Clin Infect Dis 23:402\u2013403","journal-title":"Clin Infect Dis"},{"key":"9203_CR175","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1128\/JVI.78.9.4884-4891.2004","volume":"78","author":"P Seth","year":"2004","unstructured":"Seth P, Diaz F, Tao-Cheng JH, Major EO (2004) JC virus induces nonapoptotic cell death of human central nervous system progenitor cell-derived astrocytes. J Virol 78:4884\u20134891","journal-title":"J Virol"},{"key":"9203_CR176","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0014-5793(91)80409-V","volume":"281","author":"AK Sharma","year":"1991","unstructured":"Sharma AK, Kumar G (1991) A 53\u00a0kDa protein binds to the negative regulatory region of JC virus early promoter. FEBS Lett 281:272\u2013274","journal-title":"FEBS Lett"},{"key":"9203_CR177","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/viro.1996.8409","volume":"228","author":"T Shinohara","year":"1997","unstructured":"Shinohara T, Nagashima K, Major EO (1997) Propagation of the human polyomavirus, JCV, in human neuroblastoma cell lines. Virology 228:269\u2013277","journal-title":"Virology"},{"issue":"Pt 6","key":"9203_CR178","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1099\/0022-1317-75-6-1281","volume":"75","author":"CV Shivakumar","year":"1994","unstructured":"Shivakumar CV, Das GC (1994) Biochemical and mutational analysis of the polyomavirus core promoter: involvement of nuclear factor-1 in early promoter function. J Gen Virol 75(Pt 6):1281\u20131290","journal-title":"J Gen Virol"},{"key":"9203_CR179","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1600-0404.1994.tb02755.x","volume":"90","author":"EJ Singer","year":"1994","unstructured":"Singer EJ, Stoner GL, Singer P, Tomiyasu U, Licht E, Fahy-Chandon B, Tourtellotte WW (1994) AIDS presenting as progressive multifocal leukoencephalopathy with clinical response to zidovudine. Acta Neurol Scand 90:443\u2013447","journal-title":"Acta Neurol Scand"},{"key":"9203_CR180","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1212\/WNL.32.2.200","volume":"32","author":"CR Smith","year":"1982","unstructured":"Smith CR, Sima AA, Salit IE, Gentili F (1982) Progressive multifocal leukoencephalopathy: failure of cytarabine therapy. Neurology 32:200\u2013203","journal-title":"Neurology"},{"key":"9203_CR181","first-page":"215","volume":"8","author":"JM Sobell","year":"2009","unstructured":"Sobell JM, Weinberg JM (2009) Patient fatalities potentially associated with efalizumab use. J Drugs Dermatol 8:215","journal-title":"J Drugs Dermatol"},{"key":"9203_CR182","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1128\/MCB.19.4.2455","volume":"19","author":"E Sock","year":"1999","unstructured":"Sock E, Enderich J, Wegner M (1999) The J domain of papovaviral large tumor antigen is required for synergistic interaction with the POU-domain protein Tst-1\/Oct6\/SCIP. Mol Cell Biol 19:2455\u20132464","journal-title":"Mol Cell Biol"},{"key":"9203_CR183","doi-asserted-by":"crossref","first-page":"7780","DOI":"10.1038\/sj.onc.1210875","volume":"26","author":"P Soulas-Sprauel","year":"2007","unstructured":"Soulas-Sprauel P, Rivera-Munoz P, Malivert L, Le Guyader G, Abramowski V, Revy P, de Villartay JP (2007) V(D)J and immunoglobulin class switch recombinations: a paradigm to study the regulation of DNA end-joining. Oncogene 26:7780\u20137791","journal-title":"Oncogene"},{"key":"9203_CR184","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/ana.410330415","volume":"33","author":"MJ Steiger","year":"1993","unstructured":"Steiger MJ, Tarnesby G, Gabe S, McLaughlin J, Schapira AH (1993) Successful outcome of progressive multifocal leukoencephalopathy with cytarabine and interferon. Ann Neurol 33:407\u2013411","journal-title":"Ann Neurol"},{"key":"9203_CR185","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jns.2009.02.357","volume":"280","author":"K Stieglbauer","year":"2009","unstructured":"Stieglbauer K, Topakian R, Schaffer V, Aichner FT (2009) Rituximab for myasthenia gravis: three case reports and review of the literature. J Neurol Sci 280:120\u2013122","journal-title":"J Neurol Sci"},{"key":"9203_CR186","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/13550289609146542","volume":"2","author":"C Sumner","year":"1996","unstructured":"Sumner C, Shinohara T, Durham L, Traub R, Major EO, Amemiya K (1996) Expression of multiple classes of the nuclear factor-1 family in the developing human brain: differential expression of two classes of NF-1 genes. J Neurovirology 2:87\u2013100","journal-title":"J Neurovirology"},{"key":"9203_CR187","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1348-0421.2007.tb03907.x","volume":"51","author":"Y Sunden","year":"2007","unstructured":"Sunden Y, Semba S, Suzuki T, Okada Y, Orba Y, Nagashima K, Umemura T, Sawa H (2007a) DDX1 promotes proliferation of the JC virus through transactivation of its promoter. Microbiol Immunol 51:339\u2013347","journal-title":"Microbiol Immunol"},{"key":"9203_CR188","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1348-0421.2007.tb03915.x","volume":"51","author":"Y Sunden","year":"2007","unstructured":"Sunden Y, Semba S, Suzuki T, Okada Y, Orba Y, Nagashima K, Umemura T, Sawa H (2007b) Identification of DDX1 as a JC virus transcriptional control region-binding protein. Microbiol Immunol 51:327\u2013337","journal-title":"Microbiol Immunol"},{"key":"9203_CR189","first-page":"263","volume":"67","author":"PA Swamy","year":"2003","unstructured":"Swamy PA, Nardino R (2003) Progressive multifocal leukoencephalopathy in a patient with chronic myelogenous leukemia. Conn Med 67:263\u2013264","journal-title":"Conn Med"},{"key":"9203_CR190","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.1128\/JVI.66.12.6885-6892.1992","volume":"66","author":"H Tada","year":"1992","unstructured":"Tada H, Khalili K (1992) A novel sequence-specific DNA-binding protein, LCP-1, interacts with single-stranded DNA and differentially regulates early gene expression of the human neurotropic JC virus. J Virol 66:6885\u20136892","journal-title":"J Virol"},{"key":"9203_CR191","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0006-291X(88)80265-1","volume":"157","author":"T Tamura","year":"1988","unstructured":"Tamura T, Inoue T, Nagata K, Mikoshiba K (1988) Enhancer of human polyoma JC virus contains nuclear factor I-binding sequences; analysis using mouse brain nuclear extracts. Biochem Biophys Res Commun 157:419\u2013425","journal-title":"Biochem Biophys Res Commun"},{"key":"9203_CR192","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1086\/597117","volume":"199","author":"C Tan","year":"2009","unstructured":"Tan C, Dezube B, Bhargava P, Autissier P, Wuthrich C, Miller J, Koralnik IJ (2009) Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation. J Infect Dis 199:881\u2013888","journal-title":"J Infect Dis"},{"key":"9203_CR193","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF00314091","volume":"234","author":"K Tashiro","year":"1987","unstructured":"Tashiro K, Doi S, Moriwaka F, Maruo Y, Nomura M (1987) Progressive multifocal leucoencephalopathy with magnetic resonance imaging verification and therapeutic trials with interferon. J Neurol 234:427\u2013429","journal-title":"J Neurol"},{"key":"9203_CR194","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.revmed.2007.05.013","volume":"28","author":"B Terrier","year":"2007","unstructured":"Terrier B, Hummel A, Fakhouri F, Jablonski M, Hugle T, Gasnault J, Sanson M, Martinez F (2007) Progressive multifocal leukoencephalopathy in a non-AIDS patient: high efficiency of combined cytarabine and cidofovir. Rev Med Interne 28:488\u2013491","journal-title":"Rev Med Interne"},{"key":"9203_CR195","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.tmaid.2008.12.004","volume":"7","author":"S Toovey","year":"2009","unstructured":"Toovey S (2009) Mefloquine neurotoxicity: a literature review. Travel Med Infect Dis 7:2\u20136","journal-title":"Travel Med Infect Dis"},{"key":"9203_CR196","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/ana.410310426","volume":"31","author":"C Tornatore","year":"1992","unstructured":"Tornatore C, Berger JR, Houff SA, Curfman B, Meyers K, Winfield D, Major EO (1992) Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy. Ann Neurol 31:454\u2013462","journal-title":"Ann Neurol"},{"key":"9203_CR197","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/014107680009300710","volume":"93","author":"N Tubridy","year":"2000","unstructured":"Tubridy N, Wells C, Lewis D, Schon F (2000) Unsuccessful treatment with cidofovir and cytarabine in progressive multifocal leukoencephalopathy associated with dermatomyositis. J R Soc Med 93:374\u2013375","journal-title":"J R Soc Med"},{"key":"9203_CR198","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0042-6822(89)90425-X","volume":"170","author":"DA Vacante","year":"1989","unstructured":"Vacante DA, Traub R, Major EO (1989) Extension of JC virus host range to monkey cells by insertion of a simian virus 40 enhancer into the JC virus regulatory region. Virology 170:353\u2013361","journal-title":"Virology"},{"key":"9203_CR199","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa051586","volume":"353","author":"G Assche Van","year":"2005","unstructured":"Van Assche G, Van Ranst M, Sciot R, Dubois B, Vermeire S, Noman M, Verbeeck J, Geboes K, Robberecht W, Rutgeerts P (2005) Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn\u2019s disease. N Engl J Med 353:362\u2013368","journal-title":"N Engl J Med"},{"key":"9203_CR200","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3109\/13550280009018304","volume":"6","author":"B Vaz","year":"2000","unstructured":"Vaz B, Cinque P, Pickhardt M, Weber T (2000) Analysis of the transcriptional control region in progressive multifocal leukoencephalopathy. J Neurovirology 6:398\u2013409","journal-title":"J Neurovirology"},{"key":"9203_CR201","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/jnnp.2006.092353","volume":"77","author":"S Vulliemoz","year":"2006","unstructured":"Vulliemoz S, Lurati-Ruiz F, Borruat FX, Delavelle J, Koralnik IJ, Kuntzer T, Bogousslavsky J, Picard F, Landis T, Du Pasquier RA (2006) Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis. J Neurol Neurosurg Psychiatry 77:1079\u20131082","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9203_CR202","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJMoa0810257","volume":"361","author":"W Wenning","year":"2009","unstructured":"Wenning W, Haghikia A, Laubenberger J, Clifford DB, Behrens PF, Chan A, Gold R (2009) Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med 361:1075\u20131080","journal-title":"N Engl J Med"},{"key":"9203_CR203","first-page":"1","volume":"8","author":"MK White","year":"2009","unstructured":"White MK, Johnson EM, Khalili K (2009) Multiple roles for Puralpha in cellular and viral regulation. Cell Cycle 8:1\u20137","journal-title":"Cell Cycle"},{"key":"9203_CR204","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11940-005-0010-6","volume":"7","author":"DM Wingerchuk","year":"2005","unstructured":"Wingerchuk DM, Weinshenker BG (2005) Neuromyelitis optica. Curr Treat Options Neurol 7:173\u2013182","journal-title":"Curr Treat Options Neurol"},{"key":"9203_CR205","first-page":"541","volume":"28","author":"M Yamamoto","year":"1987","unstructured":"Yamamoto M, Kaneko K, Ohta K, Ogura Y, Ueda Y, Tazima M, Takeda F (1987) Progressive multifocal leukoencephalopathy in a child with acute lymphocytic leukemia. Rinsho Ketsueki 28:541\u2013546","journal-title":"Rinsho Ketsueki"},{"key":"9203_CR206","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/nar\/7.3.651","volume":"7","author":"RC Yang","year":"1979","unstructured":"Yang RC, Wu R (1979) Comparative study of papovavirus DNA: BKV(MM), BKV(WT) and SV40. Nucleic Acids Res 7:651\u2013668","journal-title":"Nucleic Acids Res"},{"key":"9203_CR207","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1128\/JVI.64.6.3139-3143.1990","volume":"64","author":"Y Yogo","year":"1990","unstructured":"Yogo Y, Kitamura T, Sugimoto C, Ueki T, Aso Y, Hara K, Taguchi F (1990) Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals. J Virol 64:3139\u20133143","journal-title":"J Virol"},{"key":"9203_CR208","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12185-008-0168-2","volume":"88","author":"H Yokoyama","year":"2008","unstructured":"Yokoyama H, Watanabe T, Maruyama D, Kim SW, Kobayashi Y, Tobinai K (2008) Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy: case report and review of the literature. Int J Hematol 88:443\u2013447","journal-title":"Int J Hematol"},{"key":"9203_CR209","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1182\/blood-2007-10-120329","volume":"111","author":"F Zohren","year":"2008","unstructured":"Zohren F, Toutzaris D, Klarner V, Hartung HP, Kieseier B, Haas R (2008) The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans. Blood 111:3893\u20133895","journal-title":"Blood"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-010-9203-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11481-010-9203-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-010-9203-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T17:32:43Z","timestamp":1711387963000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11481-010-9203-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,17]]},"references-count":209,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["9203"],"URL":"https:\/\/doi.org\/10.1007\/s11481-010-9203-1","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,17]]}}}